✦ LIBER ✦

Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer

✍ Scribed by Thalgott, Mark; Horn, Thomas; Heck, Matthias M; Maurer, Tobias; Eiber, Matthias; Retz, Margitta; Autenrieth, Michael; Herkommer, Kathleen; Krause, Bernd J; Gschwend, Jürgen E; Treiber, Uwe; Kübler, Hubert R

Book ID: 125403602
Publisher: BioMed Central
Year: 2014
Tongue: English
Weight: 264 KB
Volume: 7
Category: Article
ISSN: 1756-8722
DOI: 10.1186/1756-8722-7-20

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Results of a Prospective, Phas

Long-Term Results of a Prospective, Phase II Study of Long-Term Androgen Ablation, Pelvic Radiotherapy, Brachytherapy Boost, and Adjuvant Docetaxel in Patients With High-Risk Prostate Cancer

✍ Steven J. DiBiase; Arif Hussain; Ritesh Kataria; Pradip Amin; Sunakshi Bassi; Na 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib

POD-01.06: Phase II trial of weekly doce

POD-01.06: Phase II trial of weekly docetaxel and complete androgen blockade prior to radical prostatectomy in high-risk localized prostate cancer patients

✍ F.J. Gómez Veiga; A. Sousa; A. Alcaraz; J. Areal; N. Hannaoui; L.A. Aparicio; B. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Multicenter Phase II Study of Combined N

Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy Before Radical Prostatectomy for Patients With High Risk Localized Prostate Cancer

✍ Chi, Kim N.; Chin, Joseph L.; Winquist, Eric; Klotz, Laurence; Saad, Fred; Gleav 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 131 KB

Intense Androgen-Deprivation Therapy Wit

Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

✍ Taplin, M.-E.; Montgomery, B.; Logothetis, C. J.; Bubley, G. J.; Richie, J. P.; 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 316 KB

Feasibility of Radical Prostatectomy Aft

Feasibility of Radical Prostatectomy After Neoadjuvant Chemohormonal Therapy for Patients With High Risk or Locally Advanced Prostate Cancer: Results of a Phase I/II Study

✍ KONETY, BADRINATH R.; EASTHAM, JAMES A.; REUTER, VICTOR E.; SCARDINO, PETER T.; 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 72 KB